Recombinant humanised IgG4 kappa CD22Biotechnological Products & SuppliesUpdated on Dec 30, 2020 View more like this | Visit SHIRLEY, NY | Contact Dgwei Logepegeez |

The product consists of a recombinant humanised IgG4 kappa CD22-targeting monoclonal antibody covalently attached to calicheamicin derivative, N-acetyl-gamma-calicheamicin dimethylhydrazide.